{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:06:52Z","timestamp":1789110412985,"version":"build-2803163510"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24141900700"],"award-info":[{"award-number":["24141900700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400902"],"award-info":[{"award-number":["2022YFC3400902"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82588201"],"award-info":[{"award-number":["82588201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472807"],"award-info":[{"award-number":["82472807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102311286"],"award-info":[{"award-number":["252102311286"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218810","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:39:22Z","timestamp":1788244762000},"page":"218810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patient-derived organoids for hepatobiliary cancers: Molecular mechanisms, translational applications and precision therapeutics"],"prefix":"10.1016","volume":"659","author":[{"given":"Senyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongwei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218810_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218810_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218272","article-title":"Burden of primary liver cancer and underlying etiologies among young adults from 1990 to 2021 and modelled projection to 2050","volume":"642","author":"Liu","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218810_bib3","series-title":"Digestive System Tumours","author":"Board","year":"2019"},{"key":"10.1016\/j.canlet.2026.218810_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218810_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218810_bib6","first-page":"1922","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","author":"Singal","year":"2023","journal-title":"Hepatology, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","article-title":"Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218810_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.34133\/bmef.0022","article-title":"Organotypic models for functional drug testing of human cancers","volume":"4","author":"Huang","year":"2023","journal-title":"BME Front."},{"key":"10.1016\/j.canlet.2026.218810_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2019.04.039","article-title":"Organoid technology in cancer precision medicine","volume":"457","author":"Xia","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218810_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101426","article-title":"Patient-derived organoids inform pharmacogenomic vulnerabilities in liver cancer","author":"Wong","year":"2025","journal-title":"JHEP Rep, Netherlands"},{"key":"10.1016\/j.canlet.2026.218810_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.apsb.2023.09.015","article-title":"A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance","author":"Sun","year":"2024","journal-title":"Acta Pharm Sin B, Netherlands"},{"key":"10.1016\/j.canlet.2026.218810_bib12","article-title":"Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application","volume":"4","author":"Ren","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218810_bib13","article-title":"Single-cell transcriptome analysis uncovers intratumoral heterogeneity and underlying mechanisms for drug resistance in hepatobiliary tumor organoids","author":"Zhao","year":"2021","journal-title":"Adv Sci (Weinh), Germany"},{"key":"10.1016\/j.canlet.2026.218810_bib14","article-title":"3D bioprinting lobule-like hepatorganoids with induced vascularization for orthotopic implantation","author":"Yan","year":"2025","journal-title":"Mater Today Bio, England"},{"key":"10.1016\/j.canlet.2026.218810_bib15","article-title":"Micro-Engineered Organoid-on-a-Chip based on mesenchymal stromal cells to predict immunotherapy responses of HCC patients","author":"Zou","year":"2023","journal-title":"Adv Sci (Weinh), Germany"},{"key":"10.1016\/j.canlet.2026.218810_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2021.01.025","article-title":"Non-matrigel scaffolds for organoid cultures","volume":"504","author":"Kaur","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218810_bib17","article-title":"Engineered hydrogels for organoid models of human nonalcoholic Fatty liver disease","author":"Liu","year":"2025","journal-title":"Adv Sci (Weinh), Germany"},{"key":"10.1016\/j.canlet.2026.218810_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2507500122","article-title":"Invasin-functionalized PIC hydrogels enable long-term 3D culture of epithelial organoids","author":"Wijnakker","year":"2025","journal-title":"Proc Natl Acad Sci U S A, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02874-8","article-title":"A single-chain derivative of an integrin-activating antibody potentiates organoid growth in Matrigel and collagen hydrogels","author":"de Lau","year":"2025","journal-title":"Nat Biotechnol, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib20","article-title":"Tunable synthetic Hydrogel Modulates Hepatic lineage specification of human liver organoid","volume":"36","author":"Wang","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.canlet.2026.218810_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500301","article-title":"Organoid vascularization: strategies and applications","volume":"14","author":"Gao","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.canlet.2026.218810_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217122","article-title":"Establishment of advanced tumor organoids with emerging innovative technologies","volume":"598","author":"Mao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218810_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/science.adu9375","article-title":"Gastruloids enable modeling of the earliest stages of human cardiac and hepatic vascularization","volume":"388","author":"Abilez","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218810_bib24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/d41586-025-02183-9","article-title":"Mini hearts, lungs and livers made in lab now grow their own blood vessels","author":"Mallapaty","year":"2025","journal-title":"Nature, England"},{"key":"10.1016\/j.canlet.2026.218810_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122898","article-title":"Optimization of culture conditions to generate vascularized multi-lineage liver organoids with structural complexity and functionality","volume":"314","author":"Chi","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218810_bib26","series-title":"Self-Organized Vascularized Hepatic Organoids in Microcapsules for Liver Regeneration","first-page":"898","author":"Zhi","year":"2025"},{"key":"10.1016\/j.canlet.2026.218810_bib27","article-title":"Autologous Organoid-T cell Co-Culture platform for modeling of immune-mediated drug-induced liver injury","author":"Soussi","year":"2025","journal-title":"Adv Sci (Weinh), Germany"},{"key":"10.1016\/j.canlet.2026.218810_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014555","article-title":"Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma","author":"Song","year":"2026","journal-title":"J Immunother Cancer, England"},{"key":"10.1016\/j.canlet.2026.218810_bib29","article-title":"Vascularized tumor organoids enable immunotherapy testing in tumor-remodeled stroma","author":"Wimmer","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.canlet.2026.218810_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.34133\/cbsystems.0107","article-title":"Advances in the model structure of in vitro vascularized Organ-on-a-Chip","author":"Yin","year":"2024","journal-title":"Cyborg Bionic Syst, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib31","article-title":"High-throughput formation of pre-vascularized hiPSC-Derived hepatobiliary organoids on a chip via nonparenchymal cell grafting","author":"Fan","year":"2025","journal-title":"Adv Sci (Weinh), Germany"},{"key":"10.1016\/j.canlet.2026.218810_bib32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tibtech.2023.01.004","article-title":"Organs-on-chips: a decade of innovation","volume":"41","author":"Strelez","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.canlet.2026.218810_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.118057","article-title":"Determining the optimal transplantation window in hepatic organoids via real-time biosensing of vascularization and metabolic maturation utilizing the integrated organoid-on-a-chip platform","volume":"292","author":"Sun","year":"2026","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.canlet.2026.218810_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115592","article-title":"Enhancing organoid technology with carbon-based nanomaterial biosensors: advancements, challenges, and future directions","volume":"222","author":"Rezaei","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2026.218810_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100910","article-title":"Cholangiocarcinoma-on-a-chip: a human 3D platform for personalised medicine","author":"Polidoro","year":"2024","journal-title":"JHEP Rep, Netherlands"},{"key":"10.1016\/j.canlet.2026.218810_bib36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218810_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216048","article-title":"Human liver cancer organoids: biological applications, current challenges, and prospects in hepatoma therapy","volume":"555","author":"Chen","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218810_bib38","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.stem.2024.09.017","article-title":"Assembloid models of cell-cell interaction to study tissue and disease biology","volume":"31","author":"Onesto","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218810_bib39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-020-3034-x","article-title":"Creation of bladder assembloids mimicking tissue regeneration and cancer","volume":"588","author":"Kim","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218810_bib40","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1038\/s41467-024-47737-z","article-title":"A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218810_bib41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-025-09183-9","article-title":"Mouse liver assembloids model periportal architecture and biliary fibrosis","volume":"644","author":"Dowbaj","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218810_bib42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-025-09884-1","article-title":"Human assembloids recapitulate periportal liver tissue in vitro","author":"Yuan","year":"2026","journal-title":"Nature, England"},{"key":"10.1016\/j.canlet.2026.218810_bib43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hep.31653","article-title":"Organoids and spheroids as models for studying cholestatic liver injury and cholangiocarcinoma","volume":"74","author":"Sato","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218810_bib44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2025.07.014","article-title":"Patient-derived liver organoids recapitulate liver epithelial heterogeneity and enable precision modeling of alcohol-related liver disease","volume":"84","author":"Arino","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218810_bib45","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/j.scib.2025.07.021","article-title":"Construction of region-specific liver organoid and fabrication of hierarchical functional liver lobule for liver disease modeling and drug evaluation","volume":"70","author":"Liu","year":"2025","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.canlet.2026.218810_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41575-025-01162-9","article-title":"Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models","author":"Leslie","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol, England"},{"key":"10.1016\/j.canlet.2026.218810_bib47","first-page":"1424","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","author":"Broutier","year":"2017","journal-title":"Nat Med, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.678","article-title":"Patient-derived organoids for personalized gallbladder cancer modelling and drug screening","author":"Yuan","year":"2022","journal-title":"Clin Transl Med, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12935-021-02219-w","article-title":"Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids","author":"Wang","year":"2021","journal-title":"Cancer Cell Int, England"},{"key":"10.1016\/j.canlet.2026.218810_bib50","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41598-023-29065-2","article-title":"Tumor organoid biobank-new platform for medical research","author":"Xie","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218810_bib51","first-page":"582","article-title":"Establishing a cryopreserved biobank of living tumor tissues for drug sensitivity testing","author":"Chen","year":"2025","journal-title":"Bioact Mater, China"},{"key":"10.1016\/j.canlet.2026.218810_bib52","doi-asserted-by":"crossref","first-page":"eadg3358","DOI":"10.1126\/scitranslmed.adg3358","article-title":"Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology","volume":"15","author":"Ji","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218810_bib53","article-title":"Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions","volume":"5","author":"Zhu","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218810_bib74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41467-023-35896-4","article-title":"Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping","author":"Lee","year":"2023","journal-title":"Nat Commun, England"},{"key":"10.1016\/j.canlet.2026.218810_bib109","doi-asserted-by":"crossref","DOI":"10.36922\/or.8571","article-title":"Patient-derived tumor organoids-guided adjuvant chemotherapy after surgical resection of intrahepatic cholangiocarcinoma: a multicenter and retrospective study","volume":"1","author":"Zhang","year":"2025","journal-title":"Organoid Research"},{"key":"10.1016\/j.canlet.2026.218810_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217770","article-title":"SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation","volume":"625","author":"Shan","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218810_bib110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41416-022-01839-x","article-title":"Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells","volume":"127","author":"Zhou","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218810_bib89","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13045-025-01716-z","article-title":"Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution","author":"Liu","year":"2025","journal-title":"J Hematol Oncol, England"},{"key":"10.1016\/j.canlet.2026.218810_bib111","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.4251\/wjgo.v16.i10.4274","article-title":"Conversion therapy in advanced perihilar cholangiocarcinoma based on patient-derived organoids: a case report","volume":"16","author":"He","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.canlet.2026.218810_bib112","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s10620-026-09707-x","article-title":"An annotated living organoid biobank for studying gallbladder diseases and drug responses","volume":"71","author":"Dutta","year":"2026","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.canlet.2026.218810_bib113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-025-03586-2","article-title":"Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair","volume":"45","author":"Ni","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218810_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1043479","article-title":"Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models","volume":"12","author":"Tan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218810_bib54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41573-025-01317-y","article-title":"Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges","author":"Wang","year":"2026","journal-title":"Nat Rev Drug Discov, England"},{"key":"10.1016\/j.canlet.2026.218810_bib55","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","article-title":"A human liver organoid screening platform for DILI risk prediction","volume":"78","author":"Zhang","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218810_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41575-025-01116-1","article-title":"Advances in liver and pancreas organoids: how far we have come and where we go next","author":"Sljukic","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol, England"},{"key":"10.1016\/j.canlet.2026.218810_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/stmcls\/sxae070","article-title":"High-throughput solutions in tumor organoids: from culture to drug screening","author":"Zuo","year":"2025","journal-title":"Stem Cells, England"},{"key":"10.1016\/j.canlet.2026.218810_bib58","doi-asserted-by":"crossref","DOI":"10.3791\/64434","article-title":"Multiparametric Tumor organoid drug screening using widefield live-cell imaging for bulk and single-organoid analysis","author":"Le Compte","year":"2022","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.canlet.2026.218810_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216180","article-title":"Patient-derived organoids in translational oncology and drug screening","volume":"562","author":"Yang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218810_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41377-025-02177-2","article-title":"Optical coherence photoacoustic microscopy for 3D cancer model imaging with AI-assisted organoid analysis","author":"Deloria","year":"2026","journal-title":"Light Sci Appl, England"},{"key":"10.1016\/j.canlet.2026.218810_bib61","doi-asserted-by":"crossref","first-page":"8897","DOI":"10.1038\/s41467-025-63955-5","article-title":"HCS-3DX, a next-generation AI-driven automated 3D-oid high-content screening system","author":"Diosdi","year":"2025","journal-title":"Nat Commun, England"},{"key":"10.1016\/j.canlet.2026.218810_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100667","article-title":"Organoids and organs-on-chips: recent advances, applications in drug development, and regulatory challenges","volume":"6","author":"Zhou","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.canlet.2026.218810_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13287-025-04139-2","article-title":"Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling","author":"Shao","year":"2025","journal-title":"Stem Cell Res Ther, England"},{"key":"10.1016\/j.canlet.2026.218810_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.engmed.2025.100089","article-title":"Organoids pharmacology and toxicology","volume":"2","author":"Sun","year":"2025","journal-title":"EngMedicine"},{"key":"10.1016\/j.canlet.2026.218810_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202505653","article-title":"Microperfused biomimetic Liver-on-a-Chip for high-throughput hepatotoxicity screening","volume":"21","author":"Zhao","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.canlet.2026.218810_bib66","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12943-025-02429-0","article-title":"The application of organoids in treatment decision-making for digestive system cancers: progress and challenges","author":"Wang","year":"2025","journal-title":"Mol Cancer, England"},{"key":"10.1016\/j.canlet.2026.218810_bib67","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1039\/D4LC00902A","article-title":"Microfluidic organoid-slice-on-a-chip system for studying anti-cholangiocarcinoma drug efficacy and hepatorenal toxicity","volume":"25","author":"Liu","year":"2025","journal-title":"Lab Chip"},{"key":"10.1016\/j.canlet.2026.218810_bib68","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/CM9.0000000000004067","article-title":"Organoid models: regulations and prospects for the development of investigational new drugs","volume":"139","author":"Li","year":"2026","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.canlet.2026.218810_bib69","article-title":"Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity","author":"Li","year":"2019","journal-title":"JCI Insight, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj7685","article-title":"SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma","volume":"16","author":"Luk","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218810_bib90","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41392-025-02321-9","article-title":"Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma","author":"Wang","year":"2025","journal-title":"Signal Transduct Target Ther, England"},{"key":"10.1016\/j.canlet.2026.218810_bib93","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2025.09.018","article-title":"PARG inhibition halts cholangiocarcinoma progression via the hippo pathway and enhances response to chemotherapy and immunotherapy","volume":"84","author":"Yu","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218810_bib70","article-title":"NEK7-induced phosphorylation of EGFR on serine 1070 drives the acquired lenvatinib resistance in hepatocellular carcinoma","author":"Huang","year":"2025","journal-title":"Hepatology, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101271","article-title":"Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1\/FAK axis","volume":"82","author":"Cao","year":"2025","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.canlet.2026.218810_bib72","article-title":"Lactylation-Driven HECTD2 limits the response of hepatocellular carcinoma to Lenvatinib","author":"Dong","year":"2025","journal-title":"Adv Sci (Weinh), Germany"},{"key":"10.1016\/j.canlet.2026.218810_bib73","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.celrep.2018.07.001","article-title":"Organoid models of human liver cancers derived from tumor needle biopsies","volume":"24","author":"Nuciforo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218810_bib115","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.7150\/ijbs.96317","article-title":"Leveraging patient-derived organoids for personalized liver cancer treatment","volume":"20","author":"Rao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218810_bib75","article-title":"Elemene augments the effects of Anti-PD-1 immunotherapy on hepatocellular carcinoma by regulating the miR-130a-5p\/SPP\/MHC-I axis","author":"Wang","year":"2026","journal-title":"Adv Sci (Weinh), Germany"},{"key":"10.1016\/j.canlet.2026.218810_bib76","article-title":"Engineered Akkermansia muciniphila vesicles for targeted pyroptosis and trained immunity to enhance immunotherapy in hepatocellular carcinoma","volume":"7","author":"Huang","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218810_bib77","article-title":"Cancer-Associated fibroblasts promote tumor immunosuppression in hepatocellular carcinoma via the NNMT-ANGPTL4 axis","author":"Lu","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218810_bib78","first-page":"eadw7181","article-title":"Genome-wide CRISPR screen identifies splicing factor SF3B4 in driving hepatocellular carcinoma","author":"Guo","year":"2025","journal-title":"Sci Adv, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib79","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3350\/cmh.2025.0972","article-title":"ERBB3 blockade sensitizes hepatocellular carcinoma to regorafenib after first-line tyrosine kinase inhibitor resistance by inhibiting HIF1A-ABCB1 signaling","author":"Tao","year":"2026","journal-title":"Clin Mol Hepatol, Korea (South)"},{"key":"10.1016\/j.canlet.2026.218810_bib80","first-page":"116","article-title":"Identification of PRMT5 as a therapeutic target in cholangiocarcinoma","author":"Elurbide","year":"2024","journal-title":"Gut, England"},{"key":"10.1016\/j.canlet.2026.218810_bib81","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/j.apsb.2024.06.028","article-title":"Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing","author":"Fu","year":"2024","journal-title":"Acta Pharm Sin B, Netherlands"},{"key":"10.1016\/j.canlet.2026.218810_bib82","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jhep.2025.03.028","article-title":"Cisplatin-induced disruption of mitochondrial divisome leads to enhanced cisplatin resistance in cholangiocarcinoma","volume":"83","author":"Lv","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218810_bib85","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.7150\/ijbs.123085","article-title":"MYC-Mediated functional manifestation of IDH1 mutations in intrahepatic cholangiocarcinoma confers sensitivity to (+)-JQ1","author":"Wang","year":"2026","journal-title":"Int J Biol Sci, Australia"},{"key":"10.1016\/j.canlet.2026.218810_bib86","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.ymthe.2021.01.021","article-title":"The CD39(+) HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8(+) T cells exhibit potent anti-HCC activity","volume":"29","author":"Zou","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2026.218810_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121527","article-title":"Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment","volume":"284","author":"Lim","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218810_bib88","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcmgh.2020.09.003","article-title":"Cancer-Associated fibroblasts provide a stromal niche for liver cancer organoids that confers trophic effects and therapy resistance","volume":"11","author":"Liu","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218810_bib91","article-title":"Targeting sterol O-acyltransferase 1 rewires fatty acid metabolism and uncovers immune vulnerability in hepatocellular carcinoma","author":"Ma","year":"2025","journal-title":"Hepatology, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib92","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.7150\/ijbs.110947","article-title":"PARP inhibitor augments anti-tumor efficacy of DNMT inhibitor by inducing senescence in cholangiocarcinoma","author":"Wang","year":"2025","journal-title":"Int J Biol Sci, Australia"},{"key":"10.1016\/j.canlet.2026.218810_bib94","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/gutjnl-2025-335291","article-title":"Targeting Aurora kinase B regulates cholesterol metabolism and enhances chemoimmunotherapy in cholangiocarcinoma","author":"Liu","year":"2026","journal-title":"Gut, England"},{"key":"10.1016\/j.canlet.2026.218810_bib95","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13046-024-03177-7","article-title":"HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma","author":"Cigliano","year":"2024","journal-title":"J Exp Clin Cancer Res, England"},{"key":"10.1016\/j.canlet.2026.218810_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218434","article-title":"Targeting MUC16 suppresses malignant progression and chemoresistance in large-duct type intrahepatic cholangiocarcinoma","volume":"646","author":"Sang","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218810_bib97","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41587-022-01397-w","article-title":"Uncovering the mode of action of engineered T cells in patient cancer organoids","volume":"41","author":"Dekkers","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218810_bib98","first-page":"182","article-title":"Integrating ctDNA dynamics and sequential organoid drug screening enhances breast cancer treatment efficacy","author":"Liu","year":"2026","journal-title":"Cancer Res, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib99","first-page":"45","article-title":"Artificial intelligence virtual organoids (AIVOs)","author":"Bai","year":"2026","journal-title":"Bioact Mater, China"},{"key":"10.1016\/j.canlet.2026.218810_bib100","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1016\/j.cell.2024.11.015","article-title":"How to build the virtual cell with artificial intelligence: priorities and opportunities","volume":"187","author":"Bunne","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218810_bib101","first-page":"525","article-title":"AI-enabled organoids: construction, analysis, and application","author":"Bai","year":"2024","journal-title":"Bioact Mater, China"},{"key":"10.1016\/j.canlet.2026.218810_bib102","first-page":"1","article-title":"From equations to agents: the artificial intelligence virtual cell reshaping precision oncology","author":"Wei","year":"2026","journal-title":"The Innovation Oncology"},{"key":"10.1016\/j.canlet.2026.218810_bib103","doi-asserted-by":"crossref","first-page":"12922","DOI":"10.1109\/TPAMI.2023.3243465","article-title":"Video Transformers: a survey","volume":"45","author":"Selva","year":"2023","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"10.1016\/j.canlet.2026.218810_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111946","article-title":"In silico models for dynamic connected cell cultures mimicking hepatocyte-endothelial cell-adipocyte interaction circle","author":"Andreoni","year":"2014","journal-title":"PLoS One, United States"},{"key":"10.1016\/j.canlet.2026.218810_bib105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tiv.2017.09.009","article-title":"Virtual cell based assay simulations of intra-mitochondrial concentrations in hepatocytes and cardiomyocytes","volume":"45","author":"Worth","year":"2017","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.canlet.2026.218810_bib106","article-title":"ODFormer: a virtual organoid for predicting personalized therapeutic responses in pancreatic cancer","author":"Xu","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.canlet.2026.218810_bib107","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","article-title":"Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression","volume":"22","author":"Seino","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218810_bib108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41592-024-02231-8","article-title":"Closing in on cancer heterogeneity with organoids","author":"Marx","year":"2024","journal-title":"Nat Methods, United States"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:32:36Z","timestamp":1789108356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":115,"alternative-id":["S0304383526005744"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218810","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived organoids for hepatobiliary cancers: Molecular mechanisms, translational applications and precision therapeutics","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218810"}}